3'-氯联苯-2-甲酸 | 73178-79-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3'-氯联苯-2-甲酸
• 中文别名: 2-(3-氯苯基)苯甲酸；2-联苯-3-氯-羧酸
• 英文名称: 3'-chloro-[1,1'-biphenyl]-2-carboxylic acid
• 英文别名: 2-(3-chlorophenyl)benzoic Acid
• CAS: 73178-79-7
• 化学式: C₁₃H₉ClO₂
• 分子量: 232.666
• InChiKey: XOBLGZILIGYWAM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(3-Chlorophenyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(3-Chlorophenyl)benzoic acid
CAS number: 73178-79-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H9ClO2
Molecular weight: 232.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3'-氯联苯-2-甲酸 在 lithium perchlorate 作用下， 以 乙腈 为溶剂， 反应 5.0h， 生成 2-chloro-6H-benzo[c]chromen-6-one
  参考文献：
  名称：

  电化学C-O键形成：容易获得芳香内酯

  摘要：

  描述了一种基于电化学技术的有效且稳健的方法，用于通过脱氢C-O环化反应直接合成芳族内酯。这种新的有用的电化学反应可以耐受各种官能团，在温和条件下可扩展至100 g。值得注意的是，可以使用含杂环的底物，从而扩大了自由基C-O环化反应的范围。

  DOI：

  10.1002/chem.201801108
• 作为产物：
  描述：

  2-碘苯甲酸甲酯 在 bis-triphenylphosphine-palladium(II) chloride 、 水 、 sodium carbonate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 生成 3'-氯联苯-2-甲酸
  参考文献：
  名称：

  芳烃的通用和实用的羧基定向远程 C?H 氧化反应

  摘要：

  已经开发了两种用于远程芳族 C  H 氧化反应的方法。方法 1，即 Cu 催化的氧化反应，对于将电子中性和富电子的联芳基羧酸环化为 3,4-苯香豆素非常有效。方法 2，K 2 S 2 O 8介导的氧化反应，对于具有给电子和吸电子基团的底物的环化更为通用和实用（见方案）。

  DOI：

  10.1002/chem.201303511

文献信息

• [EN] DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS<br/>[FR] OCTAHYDROPYRROLO [3,4-C] PYRROLES DISUBSTITUÉS UTILISÉS COMME MODULATEURS DU RÉCEPTEUR DE L'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2012145581A1

  公开（公告）日：2012-10-26

  Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  描述了二取代的八氢吡咯[3,4-c]吡咯化合物，这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和病况的方法中有用，比如失眠。
• Electrochemical C−O Bond Formation: Facile Access to Aromatic Lactones
  作者：Xiang-Zhang Tao、Jian-Jun Dai、Jie Zhou、Jun Xu、Hua-Jian Xu

  DOI：10.1002/chem.201801108

  日期：2018.5.11

  An efficient and robust methodology based on electrochemical techniques for the direct synthesis of aromatic lactones through dehydrogenative C−O cyclization is described. This new and useful electrochemical reaction can tolerate a variety of functional groups, and is scalable to 100 g under mild conditions. Remarkably, heterocycle‐containing substrates can be employed, thus expanding the scope of

  描述了一种基于电化学技术的有效且稳健的方法，用于通过脱氢C-O环化反应直接合成芳族内酯。这种新的有用的电化学反应可以耐受各种官能团，在温和条件下可扩展至100 g。值得注意的是，可以使用含杂环的底物，从而扩大了自由基C-O环化反应的范围。
• Scalable Electrochemical Dehydrogenative Lactonization of C(sp²/sp³)–H Bonds
  作者：Sheng Zhang、Lijun Li、Huiqiao Wang、Qian Li、Wenmin Liu、Kun Xu、Chengchu Zeng

  DOI：10.1021/acs.orglett.7b03617

  日期：2018.1.5

  A practical, electrochemical method is developed for the direct dehydrogenative lactonization of C(sp2/sp3)–H bonds under external oxidant- and metal-free conditions, delivering diverse lactones, including coumarin derivatives with excellent regioselectivity. The scalable nature of this newly developed electrochemical process was demonstrated on a 40 g scale following an operationally simple protocol

  开发了一种实用的电化学方法，用于在无外部氧化剂和无金属的条件下对C（sp 2 / sp 3）–H键进行直接脱氢内酯化，从而提供多种内酯，包括具有优异区域选择性的香豆素衍生物。遵循操作简单的协议，以40 g规模展示了这种新开发的电化学过程的可扩展性。C（sp 3）-H键的远程内酯化将构成朝着电化学C-O键形成的重要合成进展。
• Organocatalytic Electrochemical C–H Lactonization of Aromatic Carboxylic Acids
  作者：Sanzhong Luo、Longji Li、Qi Yang、Zongbin Jia

  DOI：10.1055/s-0036-1591558

  日期：2018.8

  Radical Methods and their Strategic Applications in Synthesis Abstract An electrochemical strategy has been developed for radical arene carbon–oxygen bond formation. This reaction utilizes DDQ as a redox mediator, with inexpensive glassy carbon electrodes to facilitate an intramolecular lactonization of biphenyl-2-carboxylic acid derivatives via aromatic carboxyl radical substitution to give 6H-be

  §这些作者同等贡献。 作为特别主题“现代自由基方法及其在合成中的战略应用”的一部分发布 抽象的 已经开发出一种用于自由基芳烃碳-氧键形成的电化学策略。该反应利用DDQ作为氧化还原介体，并具有廉价的玻璃碳电极，以通过芳族羧基自由基取代促进联苯-2-羧酸衍生物的分子内内酯化，得到6 H-苯并[ c ] chromen-6-one。 已经开发出一种用于自由基芳烃碳-氧键形成的电化学策略。该反应利用DDQ作为氧化还原介体，并具有廉价的玻璃碳电极，以通过芳族羧基自由基取代促进联苯-2-羧酸衍生物的分子内内酯化，得到6 H-苯并[ c ] chromen-6-one。
• [EN] HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES<br/>[FR] AGENTS RECEPTEURS DE L'HISTAMINE H3, PREPARATION ET UTILISATIONS THERAPEUTIQUES
  申请人：LILLY CO ELI

  公开号：WO2005097740A1

  公开（公告）日：2005-10-20

  The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases

  本发明公开了具有组合物(I)或其药学上可接受的盐的新颖化合物，其具有组胺H3受体拮抗剂或逆激动剂活性，以及制备这种化合物的方法。在另一实施例中，本发明公开了包含组合物(I)的药物组合物，以及使用它们治疗肥胖、认知缺陷、嗜睡症和其他组胺H3受体相关疾病的方法。